Federal Budget Supports USask s VIDO For Vaccine Candidates And National Centre For Pandemic Research 98cool.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 98cool.ca Daily Mail and Mail on Sunday newspapers.
By Ryan Young
Jan 11, 2021 6:43 PM
It’s expected the clinical trial for the VIDO’s COVID-19 vaccine will begin in the next week in Halifax.
The University of Saskatchewan’s Vaccine and Infections Disease Organization was given the green light for clinical trials just before Christmas.
Director and CEO, Dr. Volker Gerdts, says there is a site initiation visit today (Mon) and paperwork is being finalized.
Phase 1 will include 108 volunteers with the first being in the 18 to 54 age group, then moving to 55 to 69 year olds, followed by those 70 and older.
The testing includes 11 visits to see how the volunteers are doing and to check for any unwanted reactions.
VIDO Intervac vaccine starts clinical trials in Halifax this week By News Room
Jan 11, 2021 10:55 AM
It’s expected the clinical trial for the VIDO’s COVID-19 vaccine will begin in the next week in Halifax.
The University of Saskatchewan’s Vaccine and Infections Disease Organization was given the green light for clinical trials just before Christmas.
Director and CEO, Dr. Volker Gerdts, says there is a site initiation visit Monday and paperwork is being finalized.
Phase one will include 108 volunteers with the first being in the 18 to 54 age group, then moving to the 55 to 69 age group, followed by those 70 and older.